A R T I C L E S
Straganz and Nidetzky
hydroxyacetophenone (2′HAP) and all other chemicals were from Sigma
Aldrich (St. Louis, MO) except 1,1-difluoro-2,4-pentanedione (DFPD),
which was from Matrix Scientific (Columbia, SC). They were all of
the highest available quality and unless otherwise mentioned greater
than 97% pure. Recombinant Dke1 harboring a C-terminal decapeptide
fusion was produced and purified by affinity chromatography as
described elsewhere.10 The tagging has no effect on Dke1 activity and
specificity. The molar concentration of purified Dke1 was determined
from the absorption (at 280 nm) of the enzyme in the presence of 6 M
guanidine HCl, using an extinction coefficient of 2.1 mM-1 cm-1, which
was calculated from the tagged polypeptide sequence. Protein-bound
Fe2+ was measured using ferene S as metal chelator. The assay
employed 500 µL of an appropriately diluted protein sample that was
made anaerobically by repeated cycles of evacuation and nitrogen
flushing. The protein solution was mixed with 500 µL of a nitrogen-
purged solution of ferene S (40 mM; ∼1000-fold molar excess to the
concentration of Dke1 subunits) in 20 mM Tris/HCl, pH 7.5, and
incubated at 25 °C. The increase in absorbance at 592 nm was
monitored over time, typically up to 6 h, until it reached a constant
value. Enzyme-bound Fe2+ concentrations were calculated from the
difference of initial and final absorbance with an extinction coefficient
fluorescence titration. Among two new absorbance bands that appeared
in the spectrum of substrate-bound Dke1 compared with the spectrum
of free enzyme (see the Results section), the intensity of the band that
was lowest in energy (λ3) was chosen as reporter of the binding event.
Aliquots of ligand solution were added as described above until the
band intensity did not increase further. Because binding of most ligands
was tight relative to the enzyme concentration used in the experiment,
a significant portion of the total concentration of each binding partner
is in the binary complex at equilibrium. Therefore, eq 1 was used to
fit the data with the program Microcal Origin Pro 6.1 (OriginLab
Corporation, Northampton, MA):
A3 ) ꢀ3{(Kd + cDke1 + L) - [(Kd + cDke1 + L)2 - 4cDke1 L]0.5}/2
(1)
where A3 is the absorbance at λ3 with the corresponding absorption
coefficient ꢀ3, cDke1 is the concentration of enzyme active sites, and L
is the ligand concentration.
The fluorescence titrations were performed in the same way just
described except that cDke1 was 0.2 µM (95% Fe2+ occupancy) and the
temperature was 4 °C or 25 °C, as indicated. Experiments were
performed with a Hitachi F-4500 fluorescence spectrophotometer
(Hitachi High-Technologies, Tokyo, Japan) using excitation and
emission wavelengths of 290 and 330 nm, respectively. Constant slit
widths of 5 nm were used. The quenching of the intrinsic Dke1
tryptophan fluorescence was measured as a function of the ligand
concentration. After corrections for dilution and blank readings, data
were plotted as (I0 - I)/(I0 - I)max against L, where I0 and I are
fluorescence intensities in the absence and presence of ligand,
respectively. Equation 2 was used to fit the data:
of 35.5 mM-1 cm-1 for the stable complex between ferene S and Fe2+ 11
.
The control used 20 mM ferene S in 20 mM Tris/HCl, pH 7.5, in the
absence of Dke1.
Initial Rate Studies. Initial rates were recorded by measuring the
depletion of substrate or dioxygen. It was proven that both methods
yielded consistent results. Substrate conversion was monitored spec-
trophotometrically with a DU 800 UV-vis spectrophotometer (Beck-
mann Coulter, Inc., Fullerton, CA) at 25 °C. The wavelength of
maximum absorption for the enolate of each â-diketone at pH 7.5 (λ1)
was determined in separate experiments, as described in the Supporting
Information, and used to monitor the time course of the enzymatic
reaction. Assays were performed in a total volume of 1.5 mL. Tris/
HCl buffer, 20 mM pH 7.5, was filled into a sealed quartz cuvette and
brought to a defined concentration of dissolved dioxygen (0-1200 µM)
by flushing with mixtures of O2 and N2. Then Dke1 was added, and
I0 - I ) (I0 - I )maxL/(L + Kd)
(2)
where (I0 - I)max is the difference between I0 and I at saturating L.
Gel Filtration Analysis of the Dke1-PD Complex. A HiTrap
desalting column (5 mL, Amersham Biosciences, Uppsala, Sweden)
was used to fractionate high and low molecular weight complexes of
Fe2+ and PD. The column was equilibrated with degassed Tris/HCl
buffer (20 mM, pH 7.5) containing 5 mM PD which was added to
prevent bleaching of the chromogenic Fe2+ complex in the presence
of residual O2. The anaerobic sample (0.5 mL) contained 1 mM Dke1
active sites dissolved in the buffer supplemented with PD, and 500 µL
of it was applied to the column. It was eluted at a flow rate of 1 mL
min-1 with automatic collection of 0.5-mL fractions. Color associated
with certain fractions was clearly visible and confirmed by recording
a UV-vis spectrum. Dke1-containing fractions were identified using
the Bio-Rad protein dye binding assay (Bio-Rad, Hercules, CA).
Transient Kinetic Measurements. Stopped-flow measurements
were carried out on an Applied Photophysics instrument (model SX.18
MV, Applied Photophysics LTD, Leatherhead, U.K.) equipped with a
modular optical system. Data acquisition and analysis were done using
Applied Photophysics software. Detection was by absorbance, using a
wavelength characteristic of the free substrate enolate or the enzyme-
substrate complex (A3). Solutions of the reactants were prepared in air-
saturated 20 mM Tris/HCl buffer, pH 7.5, the cO2 being 260 µM if not
otherwise stated. From two separate syringes, 100 µL of each purified
recombinant enzyme (580 µM subunits, 75%, Fe2+ content) and
substrate (400 µM) was shot into a 20-µL flow cell having a 1-cm
path length. Alternatively, for slow reactions, a DU 800 UV-vis
spectrophotometer was used to monitor transient kinetics under
analogous conditions. All experiments were done at 25 °C in triplicate
and analyzed, and the resulting k values were averaged. Appropriate
controls were recorded in all cases to exclude the possibility of artifacts.
The observed rate constants for formation (k1) and decay (k2) of the
binary complex were obtained from nonlinear fits of the appropriate
parts of the experimental absorbance trace at A3 to eqs 3 and 4,
respectively. In eqs 3 and 4, A3,max is the theoretical maximum
the resulting dioxygen concentration (cO ) was recorded. The enzymatic
2
reactions were started by addition of substrate (3-30 µL) dissolved in
the above Tris/HCl buffer using a Hamilton syringe. It will be shown
in the Results section that Dke1 could not be saturated with dioxygen
app
cat
at the steady state. We thus define an apparent turnover number (k
)
that is the mole of substrate cleaved per mole of enzyme-bound iron
and second at the respective O2 concentration. Initial rates of dioxygen
consumption and all other cO measurements were performed with a
2
micro-optode O2 sensor (Microtox TX3-AOT, PreSens, Regensburg,
Germany) that was introduced directly into the sealed cuvette. The
sensor used noninvasive fluorescence quenching as a method of
detection.
Spectroscopic Characterization of Dke1-Substrate Complexes.
An anaerobic solution of Dke1 (270 µM subunits and 75% Fe2+ content,
giving 200 µM active sites) in 20 mM Tris buffer, pH 7.5, was prepared
in an evacuable quartz cuvette sealed with a septum. Spectroscopic
titrations were carried out by adding aliquots of 0.5-5 µL from an
anaerobic stock solution of ligand with a Hamilton syringe. Absorbance
wavelength scans in the range 300-700 nm were carried out on the
free enzyme and after each addition of ligand, and the resulting spectra
were compared after appropriate corrections for dilution. Controls were
obtained by the same procedure without Dke1, and corrections for blank
values at the corresponding ligand concentrations were made in all
cases.
Equilibrium Binding Studies. Dissociation constants (Kd) of Dke1-
substrate complexes were determined using data from absorbance or
(10) Straganz, G. D.; Slavica, A.; Hofer, H.; Mandl, U.; Steiner, W.; Nidetzky,
B. Biocatal. Biotransform., in press.
(11) Johnson-Winters, K.; Purpero, V. M.; Kavana, M.; Nelson, T.; Moran, G.
R. Biochemistry 2003, 42, 2072-2080.
9
12308 J. AM. CHEM. SOC. VOL. 127, NO. 35, 2005